SPECT brain imaging in chronic lyme disease

Clinical Nuclear Medicine

Volumn 37, Issue 9, 2012, Pages

  Donta, Sam T ^a   Noto, Richard B ^b   Vento, John A ^c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

chronic; Lyme disease; neurocognitive disorder; outcomes; SPECT of the brain

Indexed keywords

CLARITHROMYCIN; HYDROXYCHLOROQUINE; TECHNETIUM 99M; TETRACYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRAIN DISEASE; BRAIN PERFUSION; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FRONTAL LOBE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

ANTI-BACTERIAL AGENTS; BRAIN; CHRONIC DISEASE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; NEUROIMAGING; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84865576750     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318262ad9b     Document Type: Article

References (22)

1. Donta ST. Chronic and late Lyme disease. Med Clin North Am. 2002;86: 341-349.
2. Fallon BA, Das S, Plutchok JJ, et al. Functional brain imaging and neuropsychological testing in Lyme disease. Clin Infect Dis. 1997;25:S57-S63.
3. Silbersweig DA, Stern E. Symptom localization in neuropsychiatry. A functional neuroimaging approach. Ann N Y Acad Sci. 1997;835:410-420. (Pubitemid 28046123)
4. Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis. 1999;180:377-383. (Pubitemid 30256318)
5. Logigian EL, Johnson KA, Kijewski MF, et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology. 1997;49:1661-1670. (Pubitemid 28015135)
6. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry. 2003;60:221-226.
7. Fallon B, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;141:1571-1583. (Pubitemid 24337587)
8. Preac-Mursic V,Weber K, Pfister HW, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection. 1989;17:6.
9. Cadavid D, O'Neill T, Schaefer H, et al. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab Invest. 2000;80:1043-1054. (Pubitemid 30483222)
10. Donta ST. A Novel Neurotoxin of B. burgdorferi. VIII International Congress on Lyme Borreliosis. Munich, Germany; 1999.
11. Donta ST. Tetracycline therapy of chronic Lyme disease. Clin Infect Dis. 1997; 25:S52-56.
12. Donta ST. Macrolide therapy of chronic Lyme disease. Med Sci Monit. 2003; 9:136-142.
13. Coyle PK. Lyme disease. Curr Neurol Neurosci Rep. 2002;2:479-487.
14. Abdel-Dayem HM, Abu-Judeh H, Kumar M, et al. SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury. Clin Nucl Med. 1998; 23:309-317. (Pubitemid 28201734)
15. Browndyke JN, Tucker KA, Woods SP, et al. Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abuser. J Neuroimaging. 2004;14:162-169. (Pubitemid 38391826)
16. Soderstrom H, Hultin L, Tullberg M, et al. Reduced frontotemporal perfusion in psychopathic personality. Psychiatry Res. 2002;114:81-1194.
17. Schwartz RB, Garada BM, Komaroff AL, et al. Detection of cranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. AJR Am J Roentgenol. 1994;162:934-941.
18. Schmaling KB, Lewis DH, Fiedelak JI, et al. Single-photon emission computer tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosom Med. 2003;65:129-136. (Pubitemid 36143205)
19. Ichise M, Salit IE, Abbey SE, et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun. 1992;13:767-772.
20. Pozzilli C, Passaflume D, Bernardi S, et al. SPECT, MRI, and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1991;54:110-115.
21. Newberg A, Hassan A, Alavi A. Cerebral metabolic changes associated with Lyme disease. Nuc Med Commun. 2002;23:773-777. (Pubitemid 34837008)
22. Fallon BA, Lipkin RB, Corbera KM, et al. Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy. Arch Gen Psychiatry. 2009;66:554-563.